scispace - formally typeset
N

Nanda Gamad

Researcher at Post Graduate Institute of Medical Education and Research

Publications -  21
Citations -  439

Nanda Gamad is an academic researcher from Post Graduate Institute of Medical Education and Research. The author has contributed to research in topics: Oxidative stress & Medicine. The author has an hindex of 9, co-authored 16 publications receiving 329 citations. Previous affiliations of Nanda Gamad include All India Institute of Medical Sciences.

Papers
More filters
Journal ArticleDOI

Telmisartan ameliorates cisplatin-induced nephrotoxicity by inhibiting MAPK mediated inflammation and apoptosis

TL;DR: Investigating the protective effect of telmisartan in cisplatin-induced nephrotoxicity model in rats showed maximum nephroprotective effect which could be due to maintenance of cellular redox status and inhibition of MAPK activation.
Journal ArticleDOI

Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury

TL;DR: KMP protected against IR injury by attenuating inflammation and apoptosis through the modulation of MAPK pathway by maintaining cardiac function, normalizing oxidative stress, and preserving morphological alterations.
Journal ArticleDOI

Nobiletin ameliorates cisplatin-induced acute kidney injury due to its anti-oxidant, anti-inflammatory and anti-apoptotic effects

TL;DR: The result of this study suggests the nephroprotective potential of nobiletin which may be related to its anti-oxidant, anti-apoptotic and anti-inflammatory effects.
Journal ArticleDOI

Kampeferol protects against oxidative stress and apoptotic damage in experimental model of isoproterenol-induced cardiac toxicity in rats.

TL;DR: It is revealed that KMP mitigates myocardial damage in ISO-induced cardiac injury by maintaining hemodynamic and biochemical parameters and reducing inflammation owing to its anti-apoptotic, anti-inflammatory and antioxidant activities.
Journal ArticleDOI

Metformin alleviates bleomycin-induced pulmonary fibrosis in rats: Pharmacological effects and molecular mechanisms.

TL;DR: It is suggested that metformin protects against bleomycin-induced pulmonary fibrosis through activation of AMPK and amelioration of TGF-β signaling pathways.